In a study of 501 genomes and protein-building sequences, called exomes, researchers found a newly identified member of a group of tumor suppressor genes is mutated in about 5.4% of melanomas. And these melanomas make up a particularly deadly subset in the skin cancer. Learn more
A doctor is hit with a lawsuit for malpractice and a simultaneous suit for charging too much for copying records. What can he do?
Unhappy patients discourage dermatologists and staff, and they result in negative feedback and business loss. What turns anxious and grumpy into calm and happy? A few of Dermatology Times’ Editorial Advisory Board members share their favorite tricks.
Our words carry tremendous weight. They can shape or misshape a patient’s perspective of you, of her condition, and of her treatment outcome. In the everyday hustle of seeing patients, these are things you should never say and why.
Dermatology Times invited you to share the one driving reason you entered the field of dermatology. You told us, and we listened. Here are the results.
The dermatologist community is ever-changing in many ways, including practice type and organization, lifestyle, and density from state to state. View this infographic to learn more.
These are Dr. S. Manjula Jegasothy's top picks for best skin care products in 2015.
Could the secret to happy patients be found in a smile? Dr. Richard Castellano offers his observations and advice.
Medical practices that perform fee-for-service procedures are vulnerable to employee theft. Here's what you need to know to remain vigilant.
Dr. Corey Maas provides insight into new neuromodulators currently seeking FDA approval at this year's Global Aesthetic Conference.
There is a black hole with respect to what differential diagnoses to consider when presented with a patient who has an abnormality of the nipple or areola, according to an expert. Learn more
The cumulative dose of antibiotics prescribed to treat acne can be reduced through adjunctive use of retinoids or benzoyl peroxide.
The ghosts, ghouls and goblins might be gone, but the skin problems from costumes, makeup and accessories will likely fuel post-Halloween visits to dermatologists. We asked dermatologists to comment on what colleagues are likely to see this time of year and how best to treat those skin conditions. Learn more
What’s more frightful than Halloween? What the makeup and costumes can do to children’s and adult’s skin. Dermatologists weigh in with their top tips to help patients avoid post-Halloween skin horrors. Learn more
A mission statement is a powerful tool that can drive practice growth, productivity and success when thoughtfully developed and properly utilized.
Dermatology Times editorial advisor, Dr. Elaine Siegfried continues the discussion on isotretinoin with James Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. Here, the two discuss isotretinoin dosing and side effects.
Dermatologists practicing in the States may not routinely see leishmaniasis cases, but with global travel so common today, such tropical diseases may hitch a ride with patients into dermatologic practices throughout the U.S.
This years VirginDerm 16 is the best event to meet artists and innovators in the cosmetic world today.
Dermatologists may consider referring patients who present with body dysmorphic disorder (BDD) for mental health care and/or may consider prescribing selective serotonin reuptake inhibitors (SSRIs) for these patients. Learn more
To effectively treat pigmentary disorders in skin of color patients, dermatologists need to understand important nuances in treating the darker skin types, in order to avoid making pigmentary issues worse, says an expert. Learn more
Marketing is what fuels the success of laser practices, says Michael H. Gold, M.D., medical director of a Nashville, Tenn. laser practice with more than 40 devices.
Speaking at a session on community-based partnerships with hair stylists held during the annual meeting of the American Academy of Dermatology, dermatologists said reaching out to business professionals in the community is a means of finding African-American women who have CCCA and other forms of hair loss prevalent in African-American women earlier, when they would clearly benefit from seeing a dermatologist for treatment. Learn more
Erythematotelangiectatic rosacea, characterized by diffuse and persistent facial redness and telangiectasias, is a challenging disease to treat. Recent advances in laser and light therapies appear effective in improving these symptoms.
Research into the microbiome of the skin is advancing. A greater understanding of how the different microbes interact may lead to new treatment options for conditions like rosacea, but more questions still remain.
Survival rates for lentigo maligna (LM) melanoma-type melanomas vary. Acral lentiginous melanoma has a significantly worse survival rate than other melanoma subtypes with race appearing to play a role. Another factor may be poor awareness.
Read and learn the key element to managing ulcerated pediatric hemangiomas.
Dr. Jim Leyden, an active participant in isotretinoin's drug development process, discusses many of the important initial clinical observations and those that others have made over the years.
Hormonal therapy is effective in treating acne, but patients will likely have to remain on hormonal therapy long-term to maintain the benefits.
Treating troublesome IH early can help avoid or minimize complications, but complex requirements demand that physicians and parents cultivate strong relationships and effective communication.
